Jyong Biotech Ltd. — Investor Relations & Filings
Filings indexed
64
across all filing types
Latest filing
2026-05-14
Annual Report
Country
US
United States of America
Listing
US
MENS
Jyong Biotech Ltd. is a science-driven biotechnology company focused on the development and commercialization of plant-derived drugs for urinary system diseases. The company's primary therapeutic areas include benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Its lead drug candidate, MCS-2, is a botanical formulation that has completed late-stage (Phase III) clinical trials. Leveraging a proprietary research and development platform, Jyong Biotech aims to advance its pipeline of innovative botanical medicines to address unmet medical needs in urology for a global patient population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ANNUAL REPORT | 2026-05-14 | English | |
| 6-K Filing | 2026-02-06 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-09 | English | |
| SP 15D2 | 2025-06-30 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-06-18 | English | |
| PROSPECTUS | 2025-06-18 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 46352458 | ANNUAL REPORT | 2026-05-14 | English | ||
| 32247838 | 6-K Filing | 2026-02-06 | English | ||
| 13627629 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-09 | English | ||
|
2025
12 filings
| |||||
| 13627630 | SP 15D2 | 2025-06-30 | English | ||
| 13627631 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-06-18 | English | ||
| 13627632 | PROSPECTUS | 2025-06-18 | English | ||
| 13627633 | Regulatory Filings 2025 | 2025-06-17 | English | ||
| 13627634 | Regulatory Filings 2025 | 2025-06-16 | English | ||
| 13627635 | FOR REGISTRATION OF CERTAIN CLASSES | 2025-06-12 | English | ||
| 13627637 | Regulatory Filings 2025 | 2025-06-12 | English | ||
| 13627636 | Regulatory Filings 2025 | 2025-06-12 | English | ||
| 13627638 | REGISTRATION STATEMENT | 2025-06-06 | English | ||
| 13627639 | POST-EFFECTIVE AMENDMENT | 2025-04-23 | English | ||
| 13627641 | Regulatory Filings 2025 | 2025-04-01 | English | ||
| 13627640 | Regulatory Filings 2025 | 2025-03-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for C…
|
AQST | US | Manufacturing |
|
Arbutus Biopharma Corp
Clinical-stage biopharma company developing a functional cu…
|
ABUS | US | Manufacturing |
|
Arcellx, Inc.
A clinical-stage biotech company developing immunotherapies…
|
ACLX | US | Manufacturing |
|
Arctic Bioscience
Develops pharmaceutical and nutraceutical products from mar…
|
ABS | NO | Manufacturing |
|
ArcticZymes Technologies
Develops and manufactures novel recombinant enzymes from Ar…
|
AZT | NO | Manufacturing |
|
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare a…
|
ARCT | US | Manufacturing |
|
Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combi…
|
RCUS | US | Manufacturing |
|
Arcutis Biotherapeutics, Inc.
Develops and commercializes treatments for immune-mediated …
|
ARQT | US | Manufacturing |
|
ARDELYX, INC.
Biopharmaceutical company developing medicines for cardiore…
|
ARDX | US | Manufacturing |
|
ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its prop…
|
AREC | GB | Manufacturing |
Jyong Biotech Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31202/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31202 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31202 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31202 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31202}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jyong Biotech Ltd. (id: 31202)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.